{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:21:10Z","timestamp":1787019670132,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T00:00:00Z","timestamp":1343692800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2407-12-325","type":"journal-article","created":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T18:15:11Z","timestamp":1343758511000},"source":"Crossref","is-referenced-by-count":39,"title":["LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival"],"prefix":"10.1186","volume":"12","author":[{"given":"Jan Dominik","family":"Kuhlmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Schwarzenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Wimberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Poetsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Kimmig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Kasimir-Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,31]]},"reference":[{"issue":"10 Suppl","key":"3317_CR1","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1002\/cncr.11349","volume":"97","author":"MT Goodman","year":"2003","unstructured":"Goodman MT, Howe HL, Tung KH, Hotes J, Miller BA, Coughlin SS, Chen VW: Incidence of ovarian cancer by race and ethnicity in the United States, 1992\u20131997. Cancer. 2003, 97 (10 Suppl): 2676-2685.","journal-title":"Cancer"},{"issue":"Suppl 8","key":"3317_CR2","doi-asserted-by":"crossref","first-page":"viii7","DOI":"10.1093\/annonc\/mdi961","volume":"16","author":"A du Bois","year":"2005","unstructured":"du Bois A, Quinn M, Thigpen T, Vermorken J, Avall-Lundqvist E, Bookman M, Bowtell D, Brady M, Casado A, Cervantes A, et al: 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol. 2005, 16 (Suppl 8): viii7-viii12.","journal-title":"Ann Oncol"},{"issue":"6","key":"3317_CR3","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A du Bois","year":"2009","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J: Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d\u2019Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO). Cancer. 2009, 115 (6): 1234-1244. 10.1002\/cncr.24149.","journal-title":"Cancer"},{"issue":"2","key":"3317_CR4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1053\/j.seminoncol.2008.12.003","volume":"36","author":"LP Martin","year":"2009","unstructured":"Martin LP, Schilder RJ: Management of recurrent ovarian carcinoma: current status and future directions. Semin Oncol. 2009, 36 (2): 112-125. 10.1053\/j.seminoncol.2008.12.003.","journal-title":"Semin Oncol"},{"issue":"8","key":"3317_CR5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/gcc.20882","volume":"50","author":"JD Kuhlmann","year":"2011","unstructured":"Kuhlmann JD, Schwarzenbach H, Otterbach F, Heubner M, Wimberger P, Worm KH, Kimmig R, Kasimir-Bauer S: Loss of heterozygosity proximal to the M6P\/IGF2R locus is predictive for the presence of disseminated tumor cells in the bone marrow of ovarian cancer patients before and after chemotherapy. Genes Chromosomes Cancer. 2011, 50 (8): 598-605. 10.1002\/gcc.20882. Epub 2011 May 11","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"3317_CR6","first-page":"181","volume":"1775","author":"M Fleischhacker","year":"2007","unstructured":"Fleischhacker M, Schmidt B: Circulating nucleic acids (CNAs) and cancer\u2013a survey. Biochim Biophys Acta. 2007, 1775 (1): 181-232.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"3317_CR7","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach H, Hoon DS, Pantel K: Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011, 11 (6): 426-437. 10.1038\/nrc3066.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"3317_CR8","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1002\/ijc.25602","volume":"128","author":"P Wimberger","year":"2011","unstructured":"Wimberger P, Roth C, Pantel K, Kasimir-Bauer S, Kimmig R, Schwarzenbach H: Impact of platinum-based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patients. Int J Cancer. 2011, 128 (11): 2572-2580. 10.1002\/ijc.25602. Epub 2010 Oct 26","journal-title":"Int J Cancer"},{"issue":"6","key":"3317_CR9","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/0277-5379(87)90266-5","volume":"23","author":"M Stroun","year":"1987","unstructured":"Stroun M, Anker P, Lyautey J, Lederrey C, Maurice PA: Isolation and characterization of DNA from the plasma of cancer patients. Eur J Cancer Clin Oncol. 1987, 23 (6): 707-712. 10.1016\/0277-5379(87)90266-5.","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"5","key":"3317_CR10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1159\/000226740","volume":"46","author":"M Stroun","year":"1989","unstructured":"Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C, Beljanski M: Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology. 1989, 46 (5): 318-322. 10.1159\/000226740.","journal-title":"Oncology"},{"issue":"8","key":"3317_CR11","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1158\/1078-0432.CCR-08-2592","volume":"15","author":"Y Kuang","year":"2009","unstructured":"Kuang Y, Rogers A, Yeap BY, Wang L, Makrigiorgos M, Vetrand K, Thiede S, Distel RJ, Janne PA: Noninvasive detection of EGFR T790M in gefitinib or erlotinib resistant non-small cell lung cancer. Clin Cancer Res. 2009, 15 (8): 2630-2636. 10.1158\/1078-0432.CCR-08-2592.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"3317_CR12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/nm0996-1033","volume":"2","author":"XQ Chen","year":"1996","unstructured":"Chen XQ, Stroun M, Magnenat JL, Nicod LP, Kurt AM, Lyautey J, Lederrey C, Anker P: Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med. 1996, 2 (9): 1033-1035. 10.1038\/nm0996-1033.","journal-title":"Nat Med"},{"issue":"3","key":"3317_CR13","first-page":"707","volume":"60","author":"F Coulet","year":"2000","unstructured":"Coulet F, Blons H, Cabelguenne A, Lecomte T, Lacourreye O, Brasnu D, Beaune P, Zucman J, Laurent-Puig P: Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. Cancer Res. 2000, 60 (3): 707-711.","journal-title":"Cancer Res"},{"issue":"6","key":"3317_CR14","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/ijc.11333","volume":"106","author":"Q Wang","year":"2003","unstructured":"Wang Q, Larson PS, Schlechter BL, Zahid N, Finnemore E, de las Morenas A, Blanchard RA, Rosenberg CL: Loss of heterozygosity in serial plasma DNA samples during follow-up of women with breast cancer. Int J Cancer. 2003, 106 (6): 923-929. 10.1002\/ijc.11333.","journal-title":"Int J Cancer"},{"issue":"4","key":"3317_CR15","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1373\/clinchem.2007.099333","volume":"54","author":"I Muller","year":"2008","unstructured":"Muller I, Beeger C, Alix-Panabieres C, Rebillard X, Pantel K, Schwarzenbach H: Identification of loss of heterozygosity on circulating free DNA in peripheral blood of prostate cancer patients: potential and technical improvements. Clin Chem. 2008, 54 (4): 688-696. 10.1373\/clinchem.2007.099333.","journal-title":"Clin Chem"},{"issue":"16","key":"3317_CR16","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1093\/nar\/18.16.4953","volume":"18","author":"T Hung","year":"1990","unstructured":"Hung T, Mak K, Fong K: A specificity enhancer for polymerase chain reaction. Nucleic Acids Res. 1990, 18 (16): 4953-10.1093\/nar\/18.16.4953.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"3317_CR17","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1093\/nar\/23.16.3343","volume":"23","author":"E Chevet","year":"1995","unstructured":"Chevet E, Lemaitre G, Katinka MD: Low concentrations of tetramethylammonium chloride increase yield and specificity of PCR. Nucleic Acids Res. 1995, 23 (16): 3343-3344. 10.1093\/nar\/23.16.3343.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"3317_CR18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/cncr.22076","volume":"107","author":"T Fehm","year":"2006","unstructured":"Fehm T, Braun S, Muller V, Janni W, Gebauer G, Marth C, Schindlbeck C, Wallwiener D, Borgen E, Naume B, et al: A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation. Cancer. 2006, 107 (5): 885-892. 10.1002\/cncr.22076.","journal-title":"Cancer"},{"issue":"5","key":"3317_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/0032472031000141283","volume":"1","author":"E Borgen","year":"1999","unstructured":"Borgen E, Naume B, Nesland JM, Kvalheim G, Beiske K, Fodstad O, Diel I, Solomayer EF, Theocharous P, Coombes RC, et al: Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy. 1999, 1 (5): 377-388. 10.1080\/0032472031000141283.","journal-title":"Cytotherapy"},{"issue":"1","key":"3317_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1373\/clinchem.2003.026914","volume":"50","author":"M Wang","year":"2004","unstructured":"Wang M, Block TM, Steel L, Brenner DE, Su YH: Preferential isolation of fragmented DNA enhances the detection of circulating mutated k-ras DNA. Clin Chem. 2004, 50 (1): 211-213. 10.1373\/clinchem.2003.026914.","journal-title":"Clin Chem"},{"issue":"10","key":"3317_CR21","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1440-1827.1995.tb03388.x","volume":"45","author":"T Nakamura","year":"1995","unstructured":"Nakamura T, Sakai T, Nariya S: Cell death in colorectal polyps as evaluated by in situ 3'-tailing reaction and its relationship to BCL-2 expression. Pathol Int. 1995, 45 (10): 721-728. 10.1111\/j.1440-1827.1995.tb03388.x.","journal-title":"Pathol Int"},{"key":"3317_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0378-4274(95)03550-8","volume":"82\u201383","author":"R Schulte-Hermann","year":"1995","unstructured":"Schulte-Hermann R, Bursch W, Grasl-Kraupp B, Torok L, Ellinger A, Mullauer L: Role of active cell death (apoptosis) in multi-stage carcinogenesis. Toxicol Lett. 1995, 82\u201383: 143-148.","journal-title":"Toxicol Lett"},{"issue":"6","key":"3317_CR23","first-page":"604","volume":"12","author":"N Arai","year":"1999","unstructured":"Arai N, Mitomi H, Ohtani Y, Igarashi M, Kakita A, Okayasu I: Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1\/CIP1 expression in ulcerative colitis. Mod Pathol. 1999, 12 (6): 604-611.","journal-title":"Mod Pathol"},{"issue":"1","key":"3317_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1023\/A:1006260319913","volume":"18","author":"P Anker","year":"1999","unstructured":"Anker P, Mulcahy H, Chen XQ, Stroun M: Detection of circulating tumour DNA in the blood (plasma\/serum) of cancer patients. Cancer Metastasis Rev. 1999, 18 (1): 65-73. 10.1023\/A:1006260319913.","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"3317_CR25","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1464-410X.2006.06352.x","volume":"98","author":"FK Chun","year":"2006","unstructured":"Chun FK, Muller I, Lange I, Friedrich MG, Erbersdobler A, Karakiewicz PI, Graefen M, Pantel K, Huland H, Schwarzenbach H: Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer. BJU Int. 2006, 98 (3): 544-548. 10.1111\/j.1464-410X.2006.06352.x.","journal-title":"BJU Int"},{"issue":"45","key":"3317_CR26","doi-asserted-by":"publisher","first-page":"16368","DOI":"10.1073\/pnas.0507904102","volume":"102","author":"F Diehl","year":"2005","unstructured":"Diehl F, Li M, Dressman D, He Y, Shen D, Szabo S, Diaz LA, Goodman SN, David KA, Juhl H, et al: Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci U S A. 2005, 102 (45): 16368-16373. 10.1073\/pnas.0507904102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"3317_CR27","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1038\/sj.bjc.6602635","volume":"92","author":"K Hamana","year":"2005","unstructured":"Hamana K, Uzawa K, Ogawara K, Shiiba M, Bukawa H, Yokoe H, Tanzawa H: Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma. Br J Cancer. 2005, 92 (12): 2181-2184. 10.1038\/sj.bjc.6602635.","journal-title":"Br J Cancer"},{"issue":"1","key":"3317_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jss.2009.12.032","volume":"169","author":"T Rawnaq","year":"2011","unstructured":"Rawnaq T, Schwarzenbach H, Schurr PG, Freise K, Brandl S, Izbicki JR, Kaifi JT: Monitoring of loss of heterozygosity in serum microsatellite DNA among patients with gastrointestinal stromal tumors indicates tumor recurrence. J Surg Res. 2011, 169 (1): 31-35. 10.1016\/j.jss.2009.12.032.","journal-title":"J Surg Res"},{"issue":"5","key":"3317_CR29","doi-asserted-by":"publisher","first-page":"R66","DOI":"10.1186\/bcr1772","volume":"9","author":"H Schwarzenbach","year":"2007","unstructured":"Schwarzenbach H, Muller V, Beeger C, Gottberg M, Stahmann N, Pantel K: A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer. Breast Cancer Res. 2007, 9 (5): R66-10.1186\/bcr1772.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"3317_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1245\/aso.2002.9.1.71","volume":"9","author":"JM Silva","year":"2002","unstructured":"Silva JM, Garcia JM, Dominguez G, Silva J, Miralles C, Cantos B, Coca S, Provencio M, Espana P, Bonilla F: Persistence of tumor DNA in plasma of breast cancer patients after mastectomy. Ann Surg Oncol. 2002, 9 (1): 71-76. 10.1245\/aso.2002.9.1.71.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"3317_CR31","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1023\/A:1008305412635","volume":"11","author":"R Gonzalez","year":"2000","unstructured":"Gonzalez R, Silva JM, Sanchez A, Dominguez G, Garcia JM, Chen XQ, Stroun M, Provencio M, Espana P, Anker P, et al: Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significance. Ann Oncol. 2000, 11 (9): 1097-1104. 10.1023\/A:1008305412635.","journal-title":"Ann Oncol"},{"issue":"2","key":"3317_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1158\/1535-7163.MCT-10-0788","volume":"10","author":"S Rizzo","year":"2011","unstructured":"Rizzo S, Hersey JM, Mellor P, Dai W, Santos-Silva A, Liber D, Luk L, Titley I, Carden CP, Box G, et al: Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2. Mol Cancer Ther. 2011, 10 (2): 325-335. 10.1158\/1535-7163.MCT-10-0788.","journal-title":"Mol Cancer Ther"},{"issue":"17","key":"3317_CR33","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1158\/1078-0432.CCR-09-2990","volume":"16","author":"S Zhang","year":"2010","unstructured":"Zhang S, Yu D: PI(3)king apart PTEN\u2019s role in cancer. Clin Cancer Res. 2010, 16 (17): 4325-4330. 10.1158\/1078-0432.CCR-09-2990.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3317_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1158\/0008-5472.CAN-07-2488","volume":"68","author":"H Yang","year":"2008","unstructured":"Yang H, Kong W, He L, Zhao JJ, O\u2019Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, et al: MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 2008, 68 (2): 425-433. 10.1158\/0008-5472.CAN-07-2488.","journal-title":"Cancer Res"},{"issue":"9","key":"3317_CR35","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1158\/0008-5472.CAN-2401-2","volume":"64","author":"A Goel","year":"2004","unstructured":"Goel A, Arnold CN, Niedzwiecki D, Carethers JM, Dowell JM, Wasserman L, Compton C, Mayer RJ, Bertagnolli MM, Boland CR: Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res. 2004, 64 (9): 3014-3021. 10.1158\/0008-5472.CAN-2401-2.","journal-title":"Cancer Res"},{"issue":"1","key":"3317_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0090-8258(03)00177-X","volume":"90","author":"S Makhija","year":"2003","unstructured":"Makhija S, Sit A, Edwards R, Aufman K, Weiss H, Kanbour-Shakir A, Gooding W, D\u2019Angelo G, Ferrell R, Raja S, et al: Identification of genetic alterations related to chemoresistance in epithelial ovarian cancer. Gynecol Oncol. 2003, 90 (1): 3-9. 10.1016\/S0090-8258(03)00177-X.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3317_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1023\/A:1005915420341","volume":"47","author":"AV Lee","year":"1998","unstructured":"Lee AV, Hilsenbeck SG, Yee D: IGF system components as prognostic markers in breast cancer. Breast Cancer Res Treat. 1998, 47 (3): 295-302. 10.1023\/A:1005915420341.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3317_CR38","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1023\/A:1005959218524","volume":"47","author":"AJ Oates","year":"1998","unstructured":"Oates AJ, Schumaker LM, Jenkins SB, Pearce AA, DaCosta SA, Arun B, Ellis MJ: The mannose 6-phosphate\/insulin-like growth factor 2 receptor (M6P\/IGF2R), a putative breast tumor suppressor gene. Breast Cancer Res Treat. 1998, 47 (3): 269-281. 10.1023\/A:1005959218524.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"3317_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1023\/A:1009511131541","volume":"5","author":"TL Wood","year":"2000","unstructured":"Wood TL, Richert MM, Stull MA, Allar MA: The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands. J Mammary Gland Biol Neoplasia. 2000, 5 (1): 31-42. 10.1023\/A:1009511131541.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"1","key":"3317_CR40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1096\/fasebj.11.1.9034167","volume":"11","author":"AT De Souza","year":"1997","unstructured":"De Souza AT, Yamada T, Mills JJ, Jirtle RL: Imprinted genes in liver carcinogenesis. FASEB J. 1997, 11 (1): 60-67.","journal-title":"FASEB J"},{"issue":"4","key":"3317_CR41","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/(SICI)1097-0215(20000215)85:4<466::AID-IJC4>3.0.CO;2-2","volume":"85","author":"JM Rey","year":"2000","unstructured":"Rey JM, Theillet C, Brouillet JP, Rochefort H: Stable amino-acid sequence of the mannose-6-phosphate\/insulin-like growth-factor-II receptor in ovarian carcinomas with loss of heterozygosity and in breast-cancer cell lines. Int J Cancer. 2000, 85 (4): 466-473. 10.1002\/(SICI)1097-0215(20000215)85:4<466::AID-IJC4>3.0.CO;2-2.","journal-title":"Int J Cancer"},{"issue":"2","key":"3317_CR42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1634\/theoncologist.4-2-87","volume":"4","author":"MA Bookman","year":"1999","unstructured":"Bookman MA: Extending the platinum-free interval in recurrent ovarian cancer: the role of topotecan in second-line chemotherapy. Oncologist. 1999, 4 (2): 87-94.","journal-title":"Oncologist"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-325.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-12-325\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T00:44:10Z","timestamp":1594514650000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-12-325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,31]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3317"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-12-325","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,31]]},"article-number":"325"}}